Immunopathogenesis of olmesartan‐associated enteropathy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|11-12|1303-1314

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.11-12, 2015-12, pp. : 1303-1314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letters to the Editor

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 1, 2015-01 ,pp. : 117-118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of olmesartan and enteropathy outcomes: a multi‐database study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 792-800

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Infarction Associated with Terminal Hemorrhagic Necrotizing Enteropathy (THNE): Case Report

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 11, 1975-11 ,pp. : 512-516

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Enteropathy-Associated T-Cell Lymphoma: An Algorithmic Approach

By  

Case Reports in Oncology, Vol. 2, Iss. 1, 2009-02 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

Environmental enteropathy is associated with cardiometabolic risk factors in Peruvian children

By  

Journal of Developmental Origins of Health and Disease, Vol. 8, Iss. 3, 2017-03 ,pp. : 337-348

Cambridge University Press

Access to resources Recommend Favorite